CTF Written Submission

Subject: Submission of the Healthcare Operational Evidence and Compliance Framework

March 20, 2026
  • The framework establishes cryptographically immutable log segments and standardized evidence packs for product provenance, prescription legitimacy, custody, and safety. This ensures that material risks—such as supply chain fraud, delayed recall disclosures, or compliance breaches—cannot be obscured or delayed by corporate officers, directly supporting SEC requirements for timely and accurate disclosure of material liabilities.
  • All evidence access is governed by a tiered model (Tier 0/1/2) with strict purpose limitation, time-to-live (TTL) constraints, and post-access review. No single party can override governance controls (“no-master-key” posture), and all corrections, supersessions, and revocations are non-destructive and fully auditable. This structure supports legal defensibility in audits, M&A due diligence, and regulatory investigations.
  • The framework explicitly links financially consequential actions (e.g., reimbursements, settlements, or claims) to underlying, cryptographically authenticated operational evidence. Payouts or settlements cannot proceed if evidence states (product authenticity, authorization, custody, safety) are unresolved, reducing exposure to accounting fraud and ensuring compliance with investor protection and market integrity standards

Last Reviewed or Updated: March 23, 2026